Encapsulation of stem-cell derived β-cells: A promising approach for the treatment for type 1 diabetes mellitus
- 24 December 2022
- journal article
- research article
- Published by Elsevier in Journal of Colloid and Interface Science
- Vol. 636, 90-102
Abstract
No abstract availableKeywords
Funding Information
- Fond National de la Recherche Scientific
This publication has 77 references indexed in Scilit:
- Sustained function of alginate-encapsulated human islet cell implants in the peritoneal cavity of mice leading to a pilot study in a type 1 diabetic patientDiabetologia, 2013
- A Hybrid Assembly by Encapsulation of Human Cells within Mineralised Beads for Cell TherapyPLOS ONE, 2013
- Alginate: Properties and biomedical applicationsProgress in Polymer Science, 2012
- Hybrid Shell Engineering of Animal Cells for Immune Protections and Regulation of Drug Delivery: Towards the Design of “Artificial Organs”PLOS ONE, 2011
- The reversal of diabetes in rat model using mouse insulin producing cells – A combination approach of tissue engineering and macroencapsulationActa Biomaterialia, 2011
- The Generation of Definitive Endoderm from Human Embryonic Stem Cells on 3D Biodegradable Poly(lactic-co-glycolic Acid) Scaffolds and its Comparison to those Generated on 2D Monolayer CulturesThe Open Stem Cell Journal, 2011
- Human β-cell Precursors Mature Into Functional Insulin-producing Cells in an Immunoisolation Device: Implications for Diabetes Cell TherapiesTransplantation, 2009
- The reversal of hyperglycaemia in diabetic mice using PLGA scaffolds seeded with islet-like cells derived from human embryonic stem cellsBiomaterials, 2009
- Stem cell therapy - Hype or hope? A reviewJournal of Conservative Dentistry, 2009
- Reversal of Diabetes by Pancreatic Islet Transplantation into a Subcutaneous, Neovascularized DeviceTransplantation, 2006